These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 3146035

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathology of MPTP in the marmoset.
    Gibb WR, Lees AJ, Wells FR, Barnard RO, Jenner P, Marsden CD.
    Adv Neurol; 1987; 45():187-90. PubMed ID: 3103386
    [No Abstract] [Full Text] [Related]

  • 8. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
    Gibb WR, Lees AJ, Jenner P, Marsden CD.
    Neurosci Lett; 1986 Mar 28; 65(1):79-83. PubMed ID: 3486388
    [Abstract] [Full Text] [Related]

  • 9. Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.
    Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colpaert FC.
    Neuroscience; 1991 Mar 28; 41(2-3):507-23. PubMed ID: 1870701
    [Abstract] [Full Text] [Related]

  • 10. Early-stage loss of dopamine uptake-site binding in MPTP-treated monkeys.
    Graybiel AM, Moratalla R, Quinn B, DeLanney LE, Irwin I, Langston JW.
    Adv Neurol; 1993 Mar 28; 60():34-9. PubMed ID: 8420148
    [No Abstract] [Full Text] [Related]

  • 11. MPTP-induced parkinsonism in the common marmoset: behavioral and biochemical effects.
    Jenner P, Rose S, Nomoto M, Marsden CD.
    Adv Neurol; 1987 Mar 28; 45():183-6. PubMed ID: 2881443
    [No Abstract] [Full Text] [Related]

  • 12. Primate model of parkinsonism: selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeys.
    Chiueh CC, Burns RS, Markey SP, Jacobowitz DM, Kopin IJ.
    Life Sci; 1985 Jan 21; 36(3):213-8. PubMed ID: 3871241
    [Abstract] [Full Text] [Related]

  • 13. Uptake of MPP(+) by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP.
    Javitch JA, Snyder SH.
    Eur J Pharmacol; 1984 Nov 13; 106(2):455-6. PubMed ID: 6335692
    [No Abstract] [Full Text] [Related]

  • 14. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP.
    Da Prada M, Kettler R, Keller HH, Bonetti EP, Imhof R.
    Adv Neurol; 1987 Nov 13; 45():175-8. PubMed ID: 2881442
    [No Abstract] [Full Text] [Related]

  • 15. The MPTP-treated mouse as a model of parkinsonism: how good is it?
    Heikkila RE, Sonsalla PK.
    Neurochem Int; 1992 Mar 13; 20 Suppl():299S-303S. PubMed ID: 1365446
    [No Abstract] [Full Text] [Related]

  • 16. [Parkinsonism induced by MPTP as an experimental model of Parkinson disease: similarities and differences].
    Luquin MR, Obeso JA, Herrero MT, Laguna J, Martínez-Lage JM.
    Neurologia; 1991 Oct 13; 6(8):287-94. PubMed ID: 1790005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on ultrastructure of nigral neuromelanin in Macaca fascicularis.
    Levi AC, DeMattei M, Ravazzani R, Corvetti G, Golden GT, Fariello RG.
    Neurosci Lett; 1989 Jan 30; 96(3):271-6. PubMed ID: 2785665
    [Abstract] [Full Text] [Related]

  • 19. Alterations of the central noradrenergic system in MPTP-induced monkey parkinsonism.
    Miyoshi R, Kito S, Ishida H, Katayama S.
    Res Commun Chem Pathol Pharmacol; 1988 Oct 30; 62(1):93-102. PubMed ID: 2849789
    [Abstract] [Full Text] [Related]

  • 20. 4-phenylpyridine and three other analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine lack dopaminergic nigrostriatal neurotoxicity in mice and marmosets.
    Perry TL, Jones K, Hansen S, Wall RA.
    Neurosci Lett; 1987 Mar 20; 75(1):65-70. PubMed ID: 3106859
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.